Eric Elsinghorst, Ph.D., MPH, MLS(ASCP)cm, MBcm
Department Chair, Clinical Laboratory Sciences
Program Director, Molecular Biotechnology
Research Associate Professor, Clinical Laboratory Scienceseelsinghorst@kumc.edu
Eric Elsinghorst, Ph.D., MPH, MLS(ASCP)cm MBcm, is chair of the KU Department of Clinical Laboratory Sciences and program director for the department’s NAACLS-accredited medical laboratory scientist and diagnostic molecular scientist programs. He also serves as graduate director and manages admissions and advising for the department’s master's degree in molecular biotechnology program.
As associate professor, Elsinghorst teaches undergraduate lecture and laboratory courses in advanced molecular techniques and molecular diagnostics, as well as graduate courses in molecular biotechnology.
In 1981, Elsinghorst received a bachelor's degree in biology from Canisius College in Buffalo, N.Y. He obtained a doctorate in microbiology at Cornell University in1987. He performed his postdoctoral research as a National Research Council Fellow from 1987-1989 and then served as a microbiologist at the Walter Reed Army Institute of Research in Washington, D.C. before joining the KU faculty in 1994.
Elsinghorst received the Stata Norton Distinguished Teaching Award in 2012 – one of the School of Health Professions’ highest levels of recognition for excellence in education. He also is a member of the Review Committee for Accredited Programs, National Accrediting Agency for Clinical Laboratory Sciences.
Elsinghorst’s research is centered on bacterial pathogenesis. By working to better understand the ways in which bacterial pathogens interact with their hosts to cause disease, he is contributing to the development of novel approaches in the prevention of disease.
Elsinghorst acts as an external referee for the following organizations: the United States Civilian Research and Development Foundation, the American Institute of Biological Sciences, the Military Infectious Diseases Research Program, The USDA National Research Initiative, the World Health Organization, the U.S.-Israel Binational Science Foundation and the British Columbia Health Research Foundation.